JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach.

Curr Neuropharmacol 2023 DOI: 10.2174/1570159x20666220425133824 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed

Abstract

Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach.

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Ther Adv Psychopharmacol August 1, 2014
Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens. Expert Rev Clin Pharmacol December 17, 2017
Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders Psychiatry and Clinical Psychopharmacology March 30, 2026
Therapeutic Applications of Classic Hallucinogens. Curr Top Behav Neurosci 2018 84 citations
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Psychopharmacology (Berl) March 29, 2022 14 citations